Showing recent highlights
What's New
PubMed · November 1, 2026
Researchers found that in people with type 2 diabetes and peripheral artery disease (PAD) — a condition where reduced blood flow causes pain or numbness in the legs and feet — a medication called sarpogrelate did not reduce blood thickness any better than aspirin over 24 weeks. However, both medications helped ease leg pain, and sarpogrelate also showed some improvement in cold sensations in the limbs, which is a common discomfort for people with PAD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that evolocumab, an injectable cholesterol-lowering medication that works differently from statins, helped lower 'bad' LDL cholesterol by about 58 points on average in people who already had heart disease. Across nine studies involving more than 67,000 patients, those taking evolocumab were also significantly less likely to experience serious heart problems like heart attacks or strokes, and less likely to need procedures to reopen blocked heart arteries. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that rivaroxaban — a blood-thinning medication — may help people with peripheral artery disease (a condition where arteries in the legs become narrowed, reducing blood flow) by lowering the risk of serious heart problems like heart attacks or strokes, sudden loss of blood flow to a limb, and blood clots. When taken on its own, it was also linked to a lower risk of amputation. However, the medication came with a significantly higher risk of major bleeding, which is an important trade-off for patients and their doctors to weigh carefully. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether rivaroxaban might help reduce the patient's risk of heart attack or stroke, and whether it would be safer or better than the patient's current blood thinner medication.
What's New
PubMed · November 1, 2026
Researchers found that for people with peripheral artery disease — a condition where narrowed arteries reduce blood flow to the legs — different types of supervised exercise offer different benefits. Treadmill walking was best for helping people walk farther and with less leg pain, while arm cycling (using a machine that works the arms like a bicycle) showed the strongest boost in overall heart and lung fitness. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 20, 2026
Researchers found that people with higher levels of linoleic acid — a type of healthy fat found in foods like vegetable oils, nuts, and seeds — were about 25% less likely to develop peripheral artery disease, a condition where narrowed arteries reduce blood flow, usually to the legs. This finding came from a large analysis following over 137,000 people for an average of 14 years across nine international studies. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 15, 2026
Researchers found that for people with peripheral artery disease (PAD) — a condition where narrowed arteries reduce blood flow to the legs — a counseling approach called motivational interviewing (where a coach helps someone find their own reasons to make healthy changes) helped people walk farther and lose more weight than using a smartphone app, but the benefits weren't the same for everyone. Specifically, people from racial and ethnic minority groups and those with a college education seemed to benefit more when it came to walking distance. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 6, 2026
A study found that a special balloon catheter coated with a drug called sirolimus — used to open narrowed leg arteries in people with peripheral artery disease (a condition where blood flow to the legs is reduced) — did a better job of improving the health of the artery's inner lining compared to a balloon coated with a different drug called paclitaxel (40% improvement versus 22%). The sirolimus-coated balloon also seemed to lower signs of inflammation in the body after one month, which may matter because inflammation plays a role in arteries re-narrowing after treatment. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that colchicine — an anti-inflammatory medication commonly used for gout — may help reduce serious heart problems like heart attacks or strokes in stroke survivors who also have atherosclerosis (a buildup of fatty deposits in the arteries that can restrict blood flow). Researchers saw fewer serious heart events in the group taking colchicine compared to those receiving usual care alone, though the difference was not large enough to be considered statistically definitive, meaning it could have been due to chance. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether colchicine might help prevent another stroke in the patient if the patient has atherosclerosis, based on recent research about anti-inflammatory medications.
What's New
PubMed · October 1, 2026
Researchers found that adding body awareness therapy — a gentle mind-body practice that helps people tune into how their body feels and moves — to a standard exercise program helped people with peripheral artery disease (a condition where narrowed arteries reduce blood flow, usually to the legs) walk better, build more leg strength, and feel more confident in their ability to manage their condition. Both groups improved when it came to pain and emotional well-being, but the group that added body awareness therapy made bigger gains in movement and strength. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that a hands-on therapy called osteopathic lymphatic drainage — where a practitioner uses gentle movements to help fluid flow better through the body — may offer some added benefit for people with peripheral artery disease (PAD), a condition where narrowed arteries reduce blood flow to the legs and feet, causing pain, swelling, and slow-healing wounds. The review looked at whether these techniques, used alongside standard treatments like compression wraps or medications, could help with wound healing and quality of life, though the available evidence is still very limited. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
A study found that applying a gentle electrical nerve stimulation device to the lower legs — a technique called TENS, which uses small electrical pulses through sticky pads on the skin — helped increase blood flow in the legs and allowed people with peripheral artery disease (PAD, a condition where narrowed arteries reduce blood flow to the legs) to walk farther before experiencing pain. Even just 15 minutes of this treatment showed benefits, which is exciting because PAD can make walking very difficult and painful. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 1, 2026
Researchers found that using targeted sound waves combined with tiny bubbles injected into the bloodstream helped improve blood flow and heal stubborn wounds in people with peripheral artery disease — a condition where narrowed arteries reduce blood flow to the limbs. In the study, patients who received this treatment saw their wound size shrink significantly, while wounds in the standard-care group actually grew slightly on average. This is early research and hasn't yet changed treatment guidelines.
What's New
The Lancet · September 22, 2026
Researchers found that peripheral artery disease — a condition where narrowed arteries reduce blood flow, usually to the legs — can affect far more than just physical health. Beyond chronic pain and difficulty moving around, the condition is linked to loss of independence, mental health struggles, job loss, and financial hardship. This matters because it highlights that people living with this condition may need support that goes well beyond medical treatment alone. This is early research and hasn't yet changed treatment guidelines.
What's New
The Lancet · September 22, 2026
Researchers found that most heart disease research and treatment guidelines have focused heavily on heart attacks and strokes, while largely overlooking a condition called peripheral artery disease — where narrowed arteries reduce blood flow to the legs and feet. This matters because peripheral artery disease is becoming more common worldwide and may carry serious health risks that aren't getting enough attention. This is early research and hasn't yet changed treatment guidelines.
What's New
The Lancet · September 22, 2026
Researchers found that for people with peripheral artery disease (PAD) — a condition where narrowed arteries reduce blood flow to the legs — the biggest concern isn't losing a limb, but rather the increased risk of serious heart problems like heart attacks or strokes. They also found that a structured, supervised exercise program can meaningfully help people who experience leg pain when walking (a common PAD symptom called claudication), improving how far and how well they can walk without the risks that come with procedures to surgically restore blood flow. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 15, 2026
Researchers found that bempedoic acid — a cholesterol-lowering pill sometimes used by people who can't tolerate statins — may significantly reduce the risk of serious limb complications in people with peripheral artery disease (PAD), a condition where narrowed arteries reduce blood flow to the legs. In the study, people with PAD who took bempedoic acid were about 36% less likely to experience major limb problems — such as severe pain, tissue damage, or the need for a procedure to restore blood flow — compared to those who took a placebo (a dummy pill with no active medicine). This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether bempedoic acid might help reduce the patient's risk of leg problems or needing surgery related to peripheral artery disease.
What's New
PubMed · September 1, 2026
Researchers found that a structured self-management program — where people with chronic conditions like type 2 diabetes learn skills to manage their health day-to-day — led to lasting improvements in sleep, pain, fatigue, and mood, even six months after the program ended, across many different countries. For someone with type 2 diabetes, this matters because managing a long-term condition involves a lot more than just medication — things like energy levels, sleep, and emotional well-being all affect how well someone can stay on top of their health. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that people with high levels of a blood protein called lipoprotein(a) — which can clog and inflame blood vessels — were more likely to have peripheral artery disease (a condition where blood flow to the legs is reduced) and had worse outcomes after procedures to restore that blood flow. This matters because lipoprotein(a) isn't part of a standard cholesterol test, so many patients may not know their levels are elevated. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
A study found that using a tiny ultrasound camera inside blood vessels — a tool called intravascular ultrasound, or IVUS — helped doctors make better treatment decisions during procedures for peripheral artery disease, a condition where narrowed arteries reduce blood flow to the legs. Researchers found that IVUS changed the treatment plan in nearly three out of four procedures and caught leftover blockages that a standard X-ray method (called angiography) missed, leading to blood vessels staying open more reliably over the following months. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
A study looked at whether a special wound dressing that uses gentle suction — called closed incisional negative-pressure wound therapy — could help reduce wound problems after groin surgery in people with peripheral artery disease, a condition where narrowed arteries reduce blood flow to the legs. Researchers found that about 1 in 4 patients had some kind of wound complication after surgery, but the suction dressing did not perform any better than a regular surgical dressing at preventing those problems or speeding up healing. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that peripheral artery disease — a condition where narrowed arteries reduce blood flow to the legs — is becoming more common worldwide, and they worked to get a clearer picture of exactly how many people are affected across different countries and regions in 2023. The study also looked at factors like age, sex, and income level that seem to be linked to how likely someone is to develop the condition, which could help health systems better identify and support people at risk. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · September 1, 2026
Researchers found that for people with peripheral artery disease — a condition where narrowed arteries reduce blood flow to the legs — using a procedure called atherectomy (which shaves or removes plaque buildup from artery walls) before balloon angioplasty (a procedure that widens the artery using a small inflatable balloon) led to fewer complications, less need for emergency stent placement, and better artery-staying-open rates at six months compared to balloon angioplasty alone. The combined approach also appeared to reduce the chance of the artery tearing in a way that blocks blood flow, which is a serious complication during these procedures. This is early research and hasn't yet changed treatment guidelines.
What's New
NEJM · August 29, 2026
A study found that people with coronary artery disease — a condition where the heart's arteries get narrowed or blocked — who were at high risk for serious heart problems like heart attacks or strokes may do better with two blood-thinning medications working together rather than just one. This matters because finding the right balance of blood thinners can help prevent future heart events while doctors also watch carefully for bleeding risks. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 25, 2026
A study found that a newer type of balloon procedure using a drug called sirolimus worked just as well as the more established paclitaxel-coated balloon for people with peripheral artery disease — a condition where narrowed arteries reduce blood flow to the legs. This matters because the paclitaxel-coated balloon has been linked to concerns about a possible increased risk of death, so having a similarly effective alternative could be meaningful for patients and their doctors. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · August 25, 2026
According to the American College of Cardiology, people with type 2 diabetes are at high risk for peripheral artery disease (PAD) — a condition where blood flow to the legs is reduced — but many don't have obvious symptoms, so it often goes undetected until it becomes very serious. The ACC highlights that this delayed diagnosis contributes to a disproportionately high rate of amputations in people with diabetes, and that proven treatments for PAD are not being used as often as they should be. These guidelines call for greater attention to earlier screening and more consistent use of recommended treatments to help protect people with diabetes from the most severe consequences of this condition.
Ask your doctor: Ask the doctor whether the patient should be screened for peripheral artery disease, since people with type 2 diabetes often don't notice symptoms until the problem becomes serious.
What's New
PubMed · August 24, 2026
Researchers found that two different types of specially coated balloons used to open blocked leg arteries — one coated with a drug called sirolimus and one coated with a drug called paclitaxel — produced very similar results for patients with peripheral artery disease (a condition where narrowed arteries reduce blood flow to the legs). After two years, patients in both groups reported similar improvements in quality of life and similar rates of the artery staying open without needing repeat procedures. This is early research and hasn't yet changed treatment guidelines.
What's New
JAMA · August 18, 2026
Researchers found that a diabetes medication like Ozempic or Victoza may help people who have both type 2 diabetes and PAD — a condition where narrowed arteries reduce blood flow to the legs — by lowering their chances of being hospitalized, losing a limb to amputation, or death, compared to those taking metformin. This could matter for people with type 2 diabetes because PAD is a serious complication that often goes hand-in-hand with the condition, and finding treatments that address both at once is a meaningful step forward. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 11, 2026
Researchers found that blood-thinning medications used to prevent serious heart problems like heart attacks or strokes in people with coronary artery disease come with a real trade-off: the more aggressively these medications work to prevent heart and stroke events, the more they raise the risk of dangerous bleeding, including bleeding inside the brain. This matters because it suggests there may be a limit to how much benefit patients gain from stronger blood-thinning regimens before the bleeding risks start to outweigh the rewards. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 10, 2026
Researchers looked at whether a special type of balloon procedure — one that releases medicine directly into blocked leg arteries — works better than a standard balloon procedure for people with peripheral artery disease (PAD), a condition where narrowed arteries reduce blood flow to the legs. The medicine-coated balloons are designed to help keep the arteries open longer by slowing down the process that causes them to re-narrow after treatment. This matters because PAD can lead to serious problems like pain when walking, wounds that won't heal, or even limb loss — so finding better ways to keep arteries open could make a real difference in people's quality of life. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · August 1, 2026
Researchers found that people who closely followed a Mediterranean diet — which is rich in vegetables, fruits, whole grains, and healthy fats like olive oil — had a lower risk of serious heart problems like heart attacks or strokes, as well as high blood pressure. The analysis looked at data from more than 1.4 million people across 87 studies, and even small improvements in how closely someone followed the diet were linked to meaningful benefits. This suggests that eating patterns can play an important role in heart health, and people may want to talk with their doctor about how diet fits into their overall care.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.